Toradol
Active ingredient: Ketorolac
Delivery: from 4 days
- Worldwide Delivery4-7 business days
- Quality GuaranteedOnly original products
- Bonus pillsSave up to 80%
- 24/7 SupportOur team of pharmacists is available 24/7 to help you
Ketorolac reduces the body’s production of pain-signalling prostaglandins, and Toradol tablets are used for short-term relief of moderately severe acute pain. The active ingredient is ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID) that also reduces inflammation and fever.
Product information
Toradol is a ketorolac medicine for short-term relief of moderately severe acute pain. Its active ingredient is ketorolac tromethamine, a nonsteroidal anti-inflammatory drug that also reduces inflammation and fever.
How it affects the body
Ketorolac is a nonsteroidal anti-inflammatory drug that inhibits COX-1 and COX-2 enzymes, reducing the synthesis of prostaglandins involved in pain, inflammation and fever.
Ingredients
Toradol tablets contain ketorolac tromethamine, the salt form of ketorolac. The amount used is decided individually, taking age, other medicines and health conditions into account. Ketorolac belongs to the NSAID class, which reduces pain and inflammation by limiting the activity of cyclooxygenase enzymes.
Cyclooxygenase enzymes, known as COX-1 and COX-2, help the body produce prostaglandins. Prostaglandins contribute to pain sensitivity, swelling, inflammation and fever. Ketorolac lowers prostaglandin production, which can reduce acute pain without producing the opioid effects associated with narcotic pain medication.
The FDA prescribing information describes ketorolac as a medicine for short-term management of moderately severe acute pain that requires analgesia at an opioid level [1]. Its strength makes it unsuitable for casual, prolonged self-treatment of everyday aches.
Active Ingredient and Drug Class
The active ingredient is ketorolac tromethamine. The pharmacological class is nonsteroidal anti-inflammatory drug.
Toradol can provide substantial analgesia, yet it remains an NSAID rather than an opioid analgesic. It does not create opioid euphoria or opioid-type respiratory depression, although its gastrointestinal, kidney, bleeding and cardiovascular risks require close attention.
Mechanism of Action
Ketorolac inhibits COX-1 and COX-2 activity. This reduces prostaglandins involved in pain, inflammation and fever.
One practical detail is easy to miss: stronger pain relief does not mean the treatment can safely continue for longer. Ketorolac has a restricted treatment window because risk rises with cumulative exposure.
Dosage and administration
The prescribed dose is decided individually, taking age, other medicines and health conditions into account. The tablet is taken by mouth, and the total course remains short.
- Swallow the prescribed tablet with water.
- Do not take extra tablets for pain that breaks through.
- Do not extend treatment beyond the prescribed period.
- Include previous ketorolac injections when calculating total treatment duration.
- Do not add ibuprofen, naproxen or another NSAID without explicit clinical direction.
- If a dose is missed, take it when remembered only if the next scheduled dose is not near; never double the next dose.
The FDA-approved prescribing information limits systemic ketorolac exposure because gastrointestinal bleeding and kidney toxicity can occur even during short treatment courses [2]. Dose selection becomes more cautious with advancing age, dehydration, ulcer history, bleeding disorders, heart disease or reduced kidney function.
Dose and Duration Principles
The tablet is an oral ketorolac formulation. The amount used is decided individually, taking age, other medicines and health conditions into account.
Ketorolac can accumulate as a risk even when pain relief feels acceptable. The medicine should not be continued simply because the painful condition has not resolved.
Practical Administration Rules
Do not combine prescribed ketorolac routes independently. A patient who received ketorolac injection may already have used part of the maximum systemic course.
Taking Toradol with food may reduce immediate stomach discomfort for some people, but food does not remove the risk of ulceration or gastrointestinal bleeding. Alcohol can further aggravate stomach irritation and impair judgement about warning symptoms.
When not to use it
Toradol is not suitable for everyone. It should not be used by people with active or previous serious gastrointestinal bleeding, significant kidney impairment, a history of severe NSAID allergy or a condition in which bleeding risk is unacceptable.
Cardiovascular and Blood Pressure Risks
NSAIDs can increase the risk of heart attack and stroke, especially with higher exposure or in people who already have cardiovascular disease. Ketorolac may worsen hypertension, promote fluid retention and increase the risk of heart failure.
Ketorolac is also unsuitable around coronary artery bypass graft surgery unless the treating surgical team specifically directs otherwise. Pregnancy restrictions apply, with risks becoming more significant later in pregnancy.
Bleeding and Kidney Risk Groups
Toradol is not appropriate for people with active peptic ulcer disease, gastrointestinal bleeding, severe dehydration or significant kidney disease. People with bleeding disorders require careful evaluation before treatment.
Extra caution is needed with:
- Older age
- Heart failure
- Uncontrolled hypertension
- Previous ulcer or gastrointestinal haemorrhage
- Low blood volume
- Vomiting or diarrhoea
- Poor fluid intake
- Medicines that reduce clotting
When this is not for you
Toradol is not for you if you have active or previous serious gastrointestinal bleeding, significant kidney impairment, a history of severe NSAID allergy or a condition in which bleeding risk is unacceptable. Toradol is not for you if any of these contraindications apply or if a clinician has advised against NSAIDs.
Do not use Toradol during a stomach illness with repeated vomiting or diarrhoea without a treatment review. Reduced fluid volume can make kidney injury more likely.
Possible side effects
Common adverse effects include stomach pain, nausea and headache. These symptoms may be mild, but persistent or worsening stomach discomfort deserves attention because gastrointestinal injury can develop without dramatic early warning.
Toradol can also cause stomach bleeding, anaemia, kidney damage and liver damage. Risk increases in older adults and in people with dehydration, previous ulcers, kidney disease or medicines that affect clotting.
Common Adverse Effects
Reported effects include:
- Stomach pain or indigestion
- Nausea
- Headache
- Dizziness
- Drowsiness or tiredness
- Fluid retention
- Increased blood pressure
A mild headache does not predict a severe allergic or skin reaction. Persistent headache with confusion, weakness, severe dizziness or chest symptoms requires urgent assessment.
Gastrointestinal, Kidney and Liver Injury
Seek urgent medical care for black, tarry stools, vomiting blood, severe stomach pain, fainting or unusual weakness. These may indicate stomach bleeding or anaemia.
Reduced urination, swelling of the legs, sudden weight gain, severe thirst or unusual confusion can signal kidney stress. Yellowing of the skin or eyes, dark urine, severe itching or pain beneath the right ribs may indicate liver injury.
An absence of stomach pain does not rule out internal bleeding. Some people first notice weakness, breathlessness or black stools.
Severe Hypersensitivity and Skin Reactions
Rare but serious reactions include Stevens–Johnson syndrome, toxic epidermal necrolysis and Drug Reaction with Eosinophilia and Systemic Symptoms, commonly called DRESS.
Urgent symptoms include:
- Blistering or peeling skin
- Painful sores in the mouth, eyes or genitals
- Facial or throat swelling
- Breathing difficulty
- Fever with a widespread rash
- Rash accompanied by swollen glands or marked fatigue
Stop taking the medicine and obtain urgent medical care if these symptoms appear. Do not wait for a rash to become extensive.
Therapeutic indications
Toradol is intended for short-term treatment of moderately severe acute pain. Clinicians may use ketorolac after surgery or for another acute painful condition when a strong non-opioid analgesic is appropriate. NICE guidance and Cochrane reviews support selecting acute pain treatment according to the patient’s risks and clinical needs.
It may reduce pain, inflammation and fever, but it does not correct the underlying cause of every painful condition. Persistent abdominal, chest, back or pelvic pain needs assessment rather than repeated doses.
Postoperative and Acute Pain Management
Ketorolac may form part of postoperative pain management. In some clinical plans, it helps reduce the amount of opioid analgesic required, though the choice depends on bleeding risk, kidney function, age and the type of surgery.
The medicine is designed for acute episodes. Chronic arthritis pain, recurring headaches or long-term musculoskeletal pain generally require a different treatment plan because prolonged ketorolac exposure increases the risk of stomach bleeding, kidney damage and cardiovascular complications.
Treatment Duration and Clinical Limits
Systemic ketorolac treatment, including the combined time using injection and tablets, is generally limited to a maximum of five days under the FDA-labelled regimen. The exact regimen is decided individually, taking age, other medicines and health conditions into account.
Toradol is not intended for routine long-term pain control. Older adults, people with reduced kidney function and people with a history of ulcers may need a different approach or a shorter exposure.
Comparison
Toradol may provide strong short-term analgesia, yet its duration and risk profile are stricter than those of many routine pain relievers. No option is universally preferable; the choice depends on the pain, kidney function, stomach history, cardiovascular risk and other medicines.
| Medicine or class | Main clinical distinction |
|---|---|
| Toradol / ketorolac | NSAID with strong short-term analgesia; risks include bleeding, kidney injury and cardiovascular events |
| Ibuprofen or naproxen | NSAIDs used for pain and inflammation; prolonged or combined use can also damage the stomach and kidneys |
| Tylenol / acetaminophen | Relieves pain and fever without meaningful anti-inflammatory action; excess exposure can injure the liver |
| Tramadol or hydrocodone | Opioid analgesics that can impair alertness, cause dependence and slow breathing |
| Ultracet | Combination of tramadol and acetaminophen; carries opioid and acetaminophen-related risks |
Toradol and Non-Opioid NSAIDs
Ibuprofen and naproxen may be chosen for less severe pain or longer-term inflammatory conditions when clinically appropriate. Toradol can be stronger for acute pain, but greater analgesia does not remove class-related gastrointestinal, kidney and cardiovascular risks.
Never use Toradol as an extra layer over another NSAID. The combined exposure can be harmful even when each product is taken at its usual individual dose.
Toradol and Acetaminophen
Tylenol may help pain or fever without reducing inflammation. Its main serious toxicity involves the liver, especially when several acetaminophen-containing products are taken together.
A person may unknowingly duplicate acetaminophen through cold and flu products. Ingredient review matters before any combination plan.
Toradol and Opioid Analgesics
Tramadol, hydrocodone and other opioid analgesics can cause drowsiness, constipation, dependence and respiratory depression. Toradol does not provide these opioid effects, but its own bleeding and kidney risks remain important.
A clinician may select an opioid-sparing plan for some acute pain episodes. The decision depends on the procedure, pain severity and the patient’s risk factors.
Common mistakes
The most frequent preventable problems involve duplicate NSAIDs and treatment extension.
- Taking ibuprofen or naproxen for breakthrough pain.
- Using Voltaren gel without mentioning it.
- Doubling the next tablet after a missed dose.
- Continuing Toradol because the pain remains severe.
- Forgetting that an earlier injection counts toward total ketorolac exposure.
- Taking it during dehydration from vomiting or diarrhoea.
- Ignoring black stools because there is no stomach pain.
- Using another person’s injection or prescription.
- Combining it with prednisone, anticoagulants or methotrexate without review.
- Driving after dizziness or drowsiness develops.
What doctors say
In clinical practice, prescribers usually treat ketorolac as a short-course rescue analgesic rather than a routine daily pain medicine. The practical question is not only whether it reduces pain, but whether the patient’s stomach, kidneys, blood pressure and bleeding risk can tolerate it.
Doctors also consider whether the pain has an untreated cause. Persistent pain after the planned course may indicate infection, obstruction, internal injury or a complication after surgery.
Patients often focus on pain intensity and overlook fluid intake, black stools or reduced urination. Those details can change the safety assessment quickly.
Common questions
What is the best time of day to take Toradol?
Toradol is taken at the times prescribed for the individual treatment plan, rather than at a universally preferred time of day. The FDA prescribing information from 2013 describes ketorolac as a short-term acute-pain medicine requiring controlled dosing intervals. Taking it with water and avoiding dehydration can make administration easier, while taking extra tablets at night for worsening pain is unsafe. A written schedule can help prevent accidental extra doses. Contact a clinician if the prescribed interval is unclear.
How soon can the effect of Toradol become noticeable?
Some people notice oral ketorolac relief within a few hours, although response depends on the cause and severity of pain. FDA prescribing information from 2013 describes oral ketorolac as an analgesic for acute pain rather than a treatment that removes the underlying cause. Severe pain that remains uncontrolled needs clinical reassessment instead of repeated unscheduled doses.
Which diet, exercise or habits help or hinder the result?
Adequate fluid intake supports kidney safety, while vomiting, diarrhoea, heavy alcohol intake and poor fluid intake can increase risk. Guidance from the WHO published in 2020 supports assessing hydration and the wider clinical context during pharmacological pain management. Gentle movement may be reasonable after surgery when permitted, but strenuous activity can worsen an injury and should not be used to test whether the medicine is working.
Can Toradol affect driving, concentration or work with machinery?
Dizziness, drowsiness, headache or blurred vision can make driving and machinery work unsafe. FDA prescribing information from 2013 advises caution with activities requiring alertness when such symptoms occur. Do not drive until you know how the tablet affects you, and never combine impaired alertness with alcohol or opioid analgesics.
Can alcohol be used while taking Toradol?
Alcohol can irritate the stomach and may increase the danger of gastrointestinal bleeding when combined with ketorolac. The EMA’s NSAID safety information published in 2018 supports caution when medicines with gastrointestinal and bleeding risks are used alongside aggravating substances. Avoid alcohol during the treatment course, especially if there is ulcer history, vomiting, black stool or abdominal pain.
Can Toradol be combined with ibuprofen or naproxen?
Toradol should not be combined with ibuprofen or naproxen unless a prescriber gives a specific plan. FDA prescribing information from 2013 warns against combining ketorolac with other NSAIDs because the risks of adverse effects increase without a reliable added benefit. The same caution applies to other products containing an NSAID, including some formulations of Voltaren.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Sources
- U.S. Food and Drug Administration (2013). Toradol (ketorolac tromethamine) prescribing information.
- U.S. Food and Drug Administration (2013). Ketorolac tromethamine tablets prescribing information.